Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 3.380
+0.030 (0.90%)
Aug 4, 2026, 4:27 PM CET
Nykode Therapeutics AS Revenue
In the year 2025, Nykode Therapeutics AS had annual revenue of $453.00K USD, down -95.05%.
Revenue
$453.00K
Revenue Growth
-95.05%
P/S Ratio
202.02
Revenue / Employee
$7.95K
Employees
57
Market Cap
1.09B NOK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 453.00K | -8.71M | -95.05% |
| Dec 31, 2024 | 9.16M | -4.17M | -31.26% |
| Dec 31, 2023 | 13.32M | 4.29M | 47.56% |
| Dec 31, 2022 | 9.03M | -26.74M | -74.76% |
| Dec 31, 2021 | 35.77M | -179.93M | -83.42% |
| Dec 31, 2020 | 215.70M | -1.22B | -85.01% |
| Dec 31, 2019 | 1.44B | 24.09M | 1.70% |
| Dec 31, 2018 | 1.41B | 1.41B | 118,836.18% |
| Dec 31, 2017 | 1.19M | 147.46K | 14.15% |
| Dec 31, 2016 | 1.04M | 405.57K | 63.74% |
| Dec 31, 2015 | 636.33K | -534.45K | -45.65% |
| Dec 31, 2014 | 1.17M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 128.37M |
| Arctic Bioscience AS | 42.62M |
| Oncoinvent ASA | 28.07M |
| SoftOx Solutions AS | 16.27M |
| Aqua Bio Technology ASA | 7.53M |
| Thor Medical ASA | 839.00K |
| Lytix Biopharma ASA | 377.00K |
| Circio Holding ASA | 123.00K |
Nykode Therapeutics AS News
- 13 days ago - Nykode Therapeutics AS Slides: Investor presentation - Filings
- 2 months ago - Nykode Therapeutics AS Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Nykode Therapeutics AS Quarterly report: Q1 2026 - Filings
- 2 months ago - Nykode Therapeutics AS Slides: Q1 2026 - Filings
- 2 months ago - Nykode Therapeutics AS Slides: Company presentation - Filings
- 3 months ago - Nykode Therapeutics AS Slides: 25th BioPharma Drug Discovery presentation - Filings
- 4 months ago - Nykode Therapeutics AS Slides: Development of APC-targeted antigen-apecific immune tolerance therapies for autoimmune diseases presentation - Filings
- 4 months ago - Nykode Therapeutics AS Slides: VB10.NEO presentation - Filings